Skip to main content
. 2020 Dec 22;3(12):e2030189. doi: 10.1001/jamanetworkopen.2020.30189

Table 2. Unadjusted Frequency of Self-reported Bronchitic Symptoms, Wheeze, and Shortness of Breath, by Each Exposure Variable.

Exposures No./Total (%) Prevalence of each respiratory outcome, No./Total (%)a
Bronchitic symptomsb Wheezec Shortness of breathd
Total 2553 384/2194 (17.5) 312/2396 (13.0) 488/2389 (20.4)
Frequency of nicotine vapinge
Never used 1456/2553 (57.1) 191/384 (49.7) 160/312 (51.3) 250/488 (51.2)
Lifetime but not in the past 6 mo 268/2553 (10.5) 43/384 (11.2) 31/312 (9.9) 51/488 (10.5)
Past 6 mo but not in the past 30 d 228/2553 (8.9) 35/384 (9.1) 37/312 (11.9) 55/488 (11.3)
1-2 d In the past 30 d 199/2553 (7.8) 36/384 (9.4) 26/312 (8.3) 50/488 (10.3)
≥3 d In the past 30 d 400/2553 (15.7) 79/384 (20.6) 58/312 (18.6) 82/488 (16.8)
Frequency of cannabis vapingf
Never used 1504/2553 (58.9) 185/384 (48.2) 155/312 (49.7) 256/488 (52.5)
Lifetime but not in the past 6 mo 204/2553 (8.0) 35/384 (9.1) 23/312 (7.4) 34/488 (7.0)
Past 6 mo but not in the past 30 d 490/2553 (19.2) 82/384 (21.4) 72/312 (23.1) 117/488 (24.0)
1-2 d In the past 30 d 90/2553 (3.5) 24/384 (6.3) 15/312 (4.8) 21/488 (4.3)
≥3 d In the past 30 d 155/2553 (6.1) 36/384 (9.4) 31/312 (9.9) 39/488 (8.0)
a

Column percentages for yes response reported for each respiratory health symptom.

b

Data for 359 participants was missing or not provided.

c

Data for 157 participants was missing or not provided.

d

Data for 164 participants was missing or not provided.

e

No data on nicotine vaping (n = 2).

f

No data on cannabis vaping (n = 110).